ATE518536T1 - Medizinische verwendung von 3-(2,2,2- trimethylhydrazinium) propionathydrogenfumarat und dihydrogenphosphat - Google Patents

Medizinische verwendung von 3-(2,2,2- trimethylhydrazinium) propionathydrogenfumarat und dihydrogenphosphat

Info

Publication number
ATE518536T1
ATE518536T1 AT08857026T AT08857026T ATE518536T1 AT E518536 T1 ATE518536 T1 AT E518536T1 AT 08857026 T AT08857026 T AT 08857026T AT 08857026 T AT08857026 T AT 08857026T AT E518536 T1 ATE518536 T1 AT E518536T1
Authority
AT
Austria
Prior art keywords
propionathydrogene
trimethylhydrazinium
fumarate
dihydrogen phosphate
medical use
Prior art date
Application number
AT08857026T
Other languages
English (en)
Inventor
Ilmars Stonans
Eduard Tararak
Elena Andreyeva
Original Assignee
Grindeks Jsc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40481525&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE518536(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Grindeks Jsc filed Critical Grindeks Jsc
Application granted granted Critical
Publication of ATE518536T1 publication Critical patent/ATE518536T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
AT08857026T 2007-12-04 2008-12-03 Medizinische verwendung von 3-(2,2,2- trimethylhydrazinium) propionathydrogenfumarat und dihydrogenphosphat ATE518536T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07122273 2007-12-04
EP07122272 2007-12-04
PCT/EP2008/066711 WO2009071585A1 (en) 2007-12-04 2008-12-03 Medical use of 3-(2,2,2-trimethylhydrazinium) propionate hydrogen fumarate and dihydrogen phosphate

Publications (1)

Publication Number Publication Date
ATE518536T1 true ATE518536T1 (de) 2011-08-15

Family

ID=40481525

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08857026T ATE518536T1 (de) 2007-12-04 2008-12-03 Medizinische verwendung von 3-(2,2,2- trimethylhydrazinium) propionathydrogenfumarat und dihydrogenphosphat

Country Status (32)

Country Link
US (1) US20100234459A1 (de)
EP (1) EP2222293B1 (de)
JP (1) JP2011505408A (de)
KR (1) KR20100084688A (de)
CN (1) CN101951898B (de)
AR (1) AR069521A1 (de)
AT (1) ATE518536T1 (de)
AU (1) AU2008333262A1 (de)
BR (1) BRPI0819057A2 (de)
CA (1) CA2706354C (de)
CL (1) CL2008003551A1 (de)
CO (1) CO6280477A2 (de)
CY (1) CY1112336T1 (de)
DK (1) DK2222293T3 (de)
DO (1) DOP2010000163A (de)
EA (1) EA019424B1 (de)
GE (1) GEP20125673B (de)
HR (1) HRP20110744T1 (de)
IL (1) IL205961A0 (de)
MA (1) MA31993B1 (de)
MX (1) MX2010006255A (de)
MY (1) MY150508A (de)
PA (1) PA8805901A1 (de)
PE (1) PE20091037A1 (de)
PL (1) PL2222293T3 (de)
PT (1) PT2222293E (de)
RS (1) RS51992B (de)
SI (1) SI2222293T1 (de)
TN (1) TN2010000250A1 (de)
TW (1) TW200930356A (de)
WO (1) WO2009071585A1 (de)
ZA (1) ZA201003641B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2425835A1 (de) * 2010-08-18 2012-03-07 Grindeks, a joint stock company Neuartige medizinische Verwendung von 3-(2,2,2-Trimethylhydrazinium)propionat-Dihydrat und natürlichen Flavonoid-Derivaten
TWI487524B (zh) * 2010-12-03 2015-06-11 Tetra Sia 菸鹼酸和米曲肼之新穎治療組合

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20080192T3 (hr) * 2003-08-04 2008-05-31 "Joint Stock Company Grindeks" Meldonijeve soli, postupci za njihovu pripravu i farmaceutski sastav na njihovoj osnovi

Also Published As

Publication number Publication date
SI2222293T1 (sl) 2011-12-30
AR069521A1 (es) 2010-01-27
ZA201003641B (en) 2011-03-30
DOP2010000163A (es) 2010-08-31
EP2222293A1 (de) 2010-09-01
EP2222293B1 (de) 2011-08-03
MY150508A (en) 2014-01-30
JP2011505408A (ja) 2011-02-24
MX2010006255A (es) 2011-03-15
CL2008003551A1 (es) 2010-01-22
HRP20110744T1 (hr) 2011-11-30
IL205961A0 (en) 2010-11-30
PL2222293T3 (pl) 2012-01-31
CN101951898B (zh) 2012-12-05
PE20091037A1 (es) 2009-08-19
DK2222293T3 (da) 2011-11-21
PT2222293E (pt) 2011-11-15
US20100234459A1 (en) 2010-09-16
BRPI0819057A2 (pt) 2015-05-05
EA019424B1 (ru) 2014-03-31
GEP20125673B (en) 2012-10-25
PA8805901A1 (es) 2009-07-23
CA2706354A1 (en) 2009-06-11
TW200930356A (en) 2009-07-16
AU2008333262A1 (en) 2009-06-11
CO6280477A2 (es) 2011-05-20
KR20100084688A (ko) 2010-07-27
TN2010000250A1 (en) 2011-11-11
RS51992B (sr) 2012-04-30
MA31993B1 (fr) 2011-01-03
EA201000738A1 (ru) 2011-04-29
CY1112336T1 (el) 2015-12-09
CA2706354C (en) 2013-08-13
WO2009071585A1 (en) 2009-06-11
CN101951898A (zh) 2011-01-19

Similar Documents

Publication Publication Date Title
FIC20240036I1 (fi) Geeniterapia, joka ilmentää ihmisen hyytymistekijä IX:n muunnosta R338L
ATE516286T1 (de) 5-(ä1,3,4üoxadiazol-2-yl)-1h-indazol und 5-(ä1,3, 4üthiadiazol-2-yl)-1h-indazol derivate als sgk- inhibitoren zur behandlung von diabetes
EP2007393A4 (de) Thiazol- und thiophen-analoga sowie ihre verwendung zur behandlung von autoimmunerkrankungen und karzinomen
DE502005007427D1 (de) 3-aminoindazole derivate und ihre verwendung zur behandlung sgk-bedingten krankheiten
EA200970870A1 (ru) Новое терапевтическое применение 1-[2-(2,4-диметилфенилсульфанил)фенил]пиперазина
DE602006010401D1 (de) Benzochinazolinderivate und ihre verwendung bei der behandlung von knochenerkrankungen
ATE537829T1 (de) Therapeutische verwendung von verbindungen mit kombinierter sert-, 5-ht3 und 5-ht1a-aktivität
BRPI0819575A2 (pt) "bandagens médicas e kit de bandagem médica"
ATE439863T1 (de) Ophthalmische zusammensetzungen von parasympathischen stimulantia und entzündungshemmer zur verwendung bei der behandlung von presbyopie
DK1639953T3 (da) Endomedullært söm til behandling af proximale femurfrakturer
EA201071245A1 (ru) Новые терапевтические подходы для лечения болезни альцгеймера и связанных нарушений посредством модулирования реакции клеток на стресс
EP2135858A4 (de) Zusammensetzung zur behandlung von infektionserkrankungen
ATE512970T1 (de) Dimere von artemisininderivaten, deren herstellung und deren therapeutische verwendung
DE602007011398D1 (de) Trialkylsilylbenzylaminocarboxyindole, indazole und indoline und ihre verwendung zur behandlung von cetp-vermittelten erkrankungen
DE602005009255D1 (de) Amid-prodrug von gemcitabin, zusammensetzungen und verwendung damit
ATE509621T1 (de) Verwendung von 2,5-dihydroxybenzolderivaten zur behandlung von arthritis und schmerzen
DE502005003904D1 (de) Tetrahydrobenzo (d) azepin-2-on derivate und ihre verwendung zur behandlung von kardiovaskulären krankheiten
ATE486597T1 (de) 3,4-substituierte pyrrolidin-derivate zur behandlung von hypertonie
ATE540023T1 (de) Neuartige 3-aminoalkyl-1,3-dihydro-2h-indol-2-on- derivate, ihre herstellung und therapeutische verwendung
DE602006000349D1 (de) Medizinisches Instrument mit medizinischer Behandlungselektrode
FR2949954B1 (fr) Ensemble cosmetique de maquillage et/ou de soin des matieres keratiniques.
PL1737492T3 (pl) Preparat do fotodynamicznego zwalczania mikroorganizmów i zastosowanie preparatu
ATE518536T1 (de) Medizinische verwendung von 3-(2,2,2- trimethylhydrazinium) propionathydrogenfumarat und dihydrogenphosphat
DE502006009086D1 (de) Verwendung von Propolis als Beschichtungmaterial für medizinische Implantate
ATE503481T1 (de) Verwendung von 4-cyclopropylmethoxy-n-(3,5- dichlor-1-oxidopyridin-4-yl)-5-(methoxy)-pyridi - 2-carboxamid zur behandlung von rückenmarksverletzungen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 2222293

Country of ref document: EP